EU The Final Evaluation of the Innovative Medicines Initiative Joint Undertaking (2008-2016) operating under the 7th Framework Programme

EUROPEAN COMMISSION - 20 Jun, 2017
  • Tilis
  • by Tilis October 8, 2018

You May Also Like

The Missing Link Between ESG and Corporate Innovation

https://knowledge.wharton.upenn.edu/article/the-missing-link-between-esg-and-corporate-innovation/

Tilis
Tilis

RECONCEPTUALIZING CONCEPTION: MAKING ROOM FOR ARTIFICIAL INTELLIGENCE INVENTIONS

https://digitalcommons.law.scu.edu/cgi/viewcontent.cgi?article=1685&context=chtlj

Tilis
Tilis

FARM WORKERS DURING COVID

https://focusweb.org/wp-content/uploads/2021/02/FGS_PB-1_rev-2.pdf

Tilis
Tilis